Abinash Virk

3.4k total citations · 1 hit paper
86 papers, 1.9k citations indexed

About

Abinash Virk is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Abinash Virk has authored 86 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Infectious Diseases, 30 papers in Epidemiology and 18 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Abinash Virk's work include SARS-CoV-2 and COVID-19 Research (14 papers), Antimicrobial Resistance in Staphylococcus (11 papers) and Vaccine Coverage and Hesitancy (10 papers). Abinash Virk is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (14 papers), Antimicrobial Resistance in Staphylococcus (11 papers) and Vaccine Coverage and Hesitancy (10 papers). Abinash Virk collaborates with scholars based in United States, Saudi Arabia and France. Abinash Virk's co-authors include Melanie D. Swift, James M. Steckelberg, Elie F. Berbari, Larry M. Baddour, Daniel Z. Uslan, Douglas R. Osmon, John Wilson, Nancy L. Wengenack, Todd J. Kowalski and Aaron L. Leppin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

Abinash Virk

82 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence-Based Strategies for Clinical Organizations to Address COVID-19 Vaccine Hesitancy

2020 218 citations Melanie D. Swift, Abinash Virk et al. Mayo Clinic Proceedings profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Abinash Virk United States	22	754	459	457	430	229	86	1.9k
Khitam Muhsen Israel	29	1.1k 1.5×	275 0.6×	384 0.8×	837 1.9×	96 0.4×	117	2.7k
Debra Blog United States	18	1.8k 2.4×	1.1k 2.5×	440 1.0×	711 1.7×	218 1.0×	41	3.1k
Holly A. Hill United States	30	1.2k 1.6×	1.2k 2.6×	834 1.8×	167 0.4×	465 2.0×	66	3.9k
Edwin J. Asturias United States	23	809 1.1×	521 1.1×	500 1.1×	170 0.4×	251 1.1×	111	2.1k
Tom Snelling Australia	27	771 1.0×	1.3k 2.7×	477 1.0×	205 0.5×	157 0.7×	160	2.5k
Rosa Prato Italy	27	837 1.1×	1.3k 2.8×	777 1.7×	133 0.3×	105 0.5×	140	2.4k
Marta Luisa Ciofi degli Atti Italy	35	787 1.0×	2.4k 5.2×	626 1.4×	423 1.0×	307 1.3×	183	4.0k
Stefano Tempia South Africa	32	1.0k 1.4×	2.6k 5.7×	421 0.9×	129 0.3×	158 0.7×	166	3.4k
Mazin Barry Saudi Arabia	23	1.1k 1.4×	404 0.9×	431 0.9×	129 0.3×	110 0.5×	100	2.0k
Meera Chand United Kingdom	20	2.4k 3.2×	449 1.0×	677 1.5×	88 0.2×	280 1.2×	50	3.3k

Countries citing papers authored by Abinash Virk

Since Specialization

Citations

This map shows the geographic impact of Abinash Virk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abinash Virk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abinash Virk more than expected).

Fields of papers citing papers by Abinash Virk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abinash Virk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abinash Virk. The network helps show where Abinash Virk may publish in the future.

Co-authorship network of co-authors of Abinash Virk

This figure shows the co-authorship network connecting the top 25 collaborators of Abinash Virk. A scholar is included among the top collaborators of Abinash Virk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abinash Virk. Abinash Virk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Virk, Abinash, William S. Harmsen, Paschalis Vergidis, et al.. (2025). Performance of BIOFIRE FILMARRAY pneumonia panel in suspected pneumonia: insights from a real-world study. Microbiology Spectrum. 13(7). e0057125–e0057125.

Virk, Abinash, et al.. (2024). Impact of pharmacist-led microbiology result follow-up post-discharge for patients undergoing inpatient infectious diseases consultation. SHILAP Revista de lepidopterología. 4(1). e111–e111. 1 indexed citations

Virk, Abinash, Matthew G. Johnson, Daniel Roellinger, et al.. (2023). Hybrid Immunity Provides Protective Advantage Over Vaccination or Prior Remote Coronavirus Disease 2019 Alone. Open Forum Infectious Diseases. 10(5). ofad161–ofad161. 5 indexed citations

Skrupky, Lee P., Ryan W. Stevens, Abinash Virk, et al.. (2023). Personalisation and embodiment in e‐Learning for health professionals: A randomised controlled trial. Medical Education. 58(5). 566–574. 4 indexed citations

Alder, Kareme D., et al.. (2023). Chronic Q fever presenting as bilateral extensor tenosynovitis: a case report and review of the literature. Journal of Bone and Joint Infection. 8(1). 39–44. 1 indexed citations

Caldera, Freddy, Francis A. Farraye, Brian M. Necela, et al.. (2022). Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 Vaccination. Inflammatory Bowel Diseases. 29(8). 1202–1209. 11 indexed citations

Puranik, Arjun, Patrick J. Lenehan, John C. O’Horo, et al.. (2022). Durability analysis of the highly effective BNT162b2 vaccine against COVID-19. PNAS Nexus. 1(3). pgac082–pgac082. 8 indexed citations

Pawlowski, Colin, Patrick J. Lenehan, Arjun Puranik, et al.. (2021). FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system. Med. 2(8). 979–992.e8. 112 indexed citations

Suh, Gina A., et al.. (2020). Avoiding a Medical Education Quarantine During the Pandemic. Mayo Clinic Proceedings. 95(9). S63–S65. 8 indexed citations

10.

Tan, Eugene M., Jasmine R Marcelin, & Abinash Virk. (2018). Pre-travel counseling for immunocompromised travelers: A 12-year single-center retrospective review. Infection Disease & Health. 24(1). 13–22. 6 indexed citations

11.

Virk, Abinash, Maryam Mahmood, Manju Kalra, et al.. (2017). Coxiella burnetii Multilevel Disk Space Infection, Epidural Abscess, and Vertebral Osteomyelitis Secondary to Contiguous Spread From Infected Abdominal Aortic Aneurysm or Graft: Report of 4 Cases Acquired in the US and Review of the Literature. Open Forum Infectious Diseases. 4(4). ofx192–ofx192. 8 indexed citations

12.

Tan, Eugene M., et al.. (2015). Mycobacterium avium intracellulare complex causing olecranon bursitis and prosthetic joint infection in an immunocompromised host. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 2. 1–4. 6 indexed citations

13.

Alasmari, Faisal, Imad M. Tleyjeh, Muhammad Riaz, et al.. (2012). Temporal Trends in the Incidence of Surgical Site Infections in Patients Undergoing Coronary Artery Bypass Graft Surgery: A Population-Based Cohort Study, 1993 to 2008. Mayo Clinic Proceedings. 87(11). 1054–1061. 18 indexed citations

14.

Sohail, M. Rizwan, Adam Gray, Larry M. Baddour, Imad M. Tleyjeh, & Abinash Virk. (2009). Infective endocarditis due to Propionibacterium species. Clinical Microbiology and Infection. 15(4). 387–394. 58 indexed citations

15.

Lassmann, Britta, Constantine Tsigrelis, & Abinash Virk. (2007). 33-Year-Old Woman With Marked Eosinophilia. Mayo Clinic Proceedings. 82(1). 103–106. 7 indexed citations

16.

Lassmann, Britta, Constantine Tsigrelis, & Abinash Virk. (2007). 33-Year-Old Woman With Marked Eosinophilia. Mayo Clinic Proceedings. 82(1). 103–106. 8 indexed citations

17.

Uslan, Daniel Z. & Abinash Virk. (2006). Postexposure Chemoprophylaxis for Occupational Exposure to Human Immunodeficiency Virus in Traveling Health Care Workers. Journal of Travel Medicine. 12(1). 14–18. 5 indexed citations

18.

Tleyjeh, Imad M., et al.. (2005). Cytomegalovirus cholangitis presenting with recurrent hemobilia. European Journal of Clinical Microbiology & Infectious Diseases. 24(9). 634–636. 2 indexed citations

19.

Virk, Abinash. (2001). Medical Advice for International Travelers. Mayo Clinic Proceedings. 76(8). 831–840. 10 indexed citations

20.

Virk, Abinash. (2001). Medical Advice for International Travelers. Mayo Clinic Proceedings. 76(8). 831–840. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact